Charlotte E Farquhar1, Christopher S Breivogel2, Thomas F Gamage1, Elaine A Gay1, Brian F Thomas1, Rebecca M Craft3, Jenny L Wiley4. 1. RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709-2194, USA. 2. Department of Pharmaceutical Sciences, Campbell University, Buies Creek, NC 27506, USA. 3. Department of Psychology, Washington State University, Pullman, WA 99164-4820, USA. 4. RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709-2194, USA. Electronic address: jwiley@rti.org.
Abstract
BACKGROUND: The recent NIH mandate to consider sex as a biological variable in preclinical research has focused attention on delineation of sex differences in behavior. To investigate mechanisms underlying sex differences in Δ9-tetrahydrocannabinol (THC) effects, we examined the effects of sex and gonadal hormones on CB1 receptors in cerebellum, hippocampus, prefrontal cortex, and striatum. METHODS: Adult Sprague-Dawley rats underwent gonadectomy (GDX) or sham-GDX. Half of the GDX females and males received estradiol or testosterone replacement (GDX+H), respectively. All rats were injected with vehicle or 30 mg/kg THC twice daily for 1 week before brain collection. CP55,940-stimulated [35S]GTPγS and [3H]SR141716A saturation binding assays were performed. RESULTS: With exception of enhanced receptor activation in the hippocampi of female rats compared to males, vehicle-treated rats exhibited minimal sex differences in CB1 receptor densities or G-protein coupling. Repeated treatment with THC resulted in pronounced CB1 receptor desensitization and downregulation in both sexes in all brain regions with a greater magnitude of change in females. CONCLUSIONS: These results suggest that sex differences in the density and G-protein coupling of brain CB1 receptors may play a limited role in sex differences in acute THC effects not mediated by the hippocampus. In contrast, sex differences after repeated THC were common, with females (intact, GDX, and GDX+H) showing greater downregulation or desensitization in all four brain regions compared to the respective male groups. This result is consistent with a finding that women tend to progress to tolerance and dependence quicker than men after initiation of cannabis use.
BACKGROUND: The recent NIH mandate to consider sex as a biological variable in preclinical research has focused attention on delineation of sex differences in behavior. To investigate mechanisms underlying sex differences in Δ9-tetrahydrocannabinol (THC) effects, we examined the effects of sex and gonadal hormones on CB1 receptors in cerebellum, hippocampus, prefrontal cortex, and striatum. METHODS: Adult Sprague-Dawley rats underwent gonadectomy (GDX) or sham-GDX. Half of the GDX females and males received estradiol or testosterone replacement (GDX+H), respectively. All rats were injected with vehicle or 30 mg/kg THC twice daily for 1 week before brain collection. CP55,940-stimulated [35S]GTPγS and [3H]SR141716A saturation binding assays were performed. RESULTS: With exception of enhanced receptor activation in the hippocampi of female rats compared to males, vehicle-treated rats exhibited minimal sex differences in CB1 receptor densities or G-protein coupling. Repeated treatment with THC resulted in pronounced CB1 receptor desensitization and downregulation in both sexes in all brain regions with a greater magnitude of change in females. CONCLUSIONS: These results suggest that sex differences in the density and G-protein coupling of brain CB1 receptors may play a limited role in sex differences in acute THC effects not mediated by the hippocampus. In contrast, sex differences after repeated THC were common, with females (intact, GDX, and GDX+H) showing greater downregulation or desensitization in all four brain regions compared to the respective male groups. This result is consistent with a finding that women tend to progress to tolerance and dependence quicker than men after initiation of cannabis use.
Authors: J Hirvonen; R S Goodwin; C-T Li; G E Terry; S S Zoghbi; C Morse; V W Pike; N D Volkow; M A Huestis; R B Innis Journal: Mol Psychiatry Date: 2011-07-12 Impact factor: 15.992
Authors: Julie A Marusich; Timothy W Lefever; Kateland R Antonazzo; Rebecca M Craft; Jenny L Wiley Journal: Drug Alcohol Depend Date: 2014-02-12 Impact factor: 4.492
Authors: Stéphanie E Reitsma; Hari Hara Sudhan Lakshmanan; Jennifer Johnson; Jiaqing Pang; Iván Parra-Izquierdo; Alex R Melrose; Jaewoo Choi; Deirdre E J Anderson; Monica T Hinds; Jan Frederik Stevens; Joseph E Aslan; Owen J T McCarty; Jamie O Lo Journal: Am J Physiol Cell Physiol Date: 2022-01-26 Impact factor: 4.249
Authors: Shikha Prashad; Ryan P Hammonds; Amanda L Wiese; Amber L Milligan; Francesca M Filbey Journal: Drug Alcohol Depend Date: 2020-02-19 Impact factor: 4.492
Authors: Henry L Blanton; Robert C Barnes; Melissa C McHann; Joshua A Bilbrey; Jenny L Wilkerson; Josée Guindon Journal: Pharmacol Biochem Behav Date: 2021-01-12 Impact factor: 3.533
Authors: Katherine L McPherson; Dardo G Tomasi; Gene-Jack Wang; Peter Manza; Nora D Volkow Journal: Front Psychiatry Date: 2021-05-13 Impact factor: 4.157
Authors: Christina M Ruiz; Alexa Torrens; Erik Castillo; Christina R Perrone; Jenny Cevallos; Victoria C Inshishian; Eden V Harder; Drew N Justeson; Marilyn A Huestis; Vivek Swarup; Daniele Piomelli; Stephen V Mahler Journal: Neuropsychopharmacology Date: 2020-09-14 Impact factor: 7.853
Authors: Jenny L Wiley; Daniel G Barrus; Charlotte E Farquhar; Timothy W Lefever; Thomas F Gamage Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2020-08-15 Impact factor: 5.067